CN110141528A - A kind of foam sheet mask - Google Patents
A kind of foam sheet mask Download PDFInfo
- Publication number
- CN110141528A CN110141528A CN201910374527.3A CN201910374527A CN110141528A CN 110141528 A CN110141528 A CN 110141528A CN 201910374527 A CN201910374527 A CN 201910374527A CN 110141528 A CN110141528 A CN 110141528A
- Authority
- CN
- China
- Prior art keywords
- facial mask
- surfactant
- foaming
- mask
- patch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006260 foam Substances 0.000 title claims abstract description 36
- 239000004744 fabric Substances 0.000 claims abstract description 68
- 230000001815 facial effect Effects 0.000 claims abstract description 64
- 239000004094 surface-active agent Substances 0.000 claims abstract description 60
- 239000007788 liquid Substances 0.000 claims abstract description 57
- 238000005187 foaming Methods 0.000 claims abstract description 48
- 230000008719 thickening Effects 0.000 claims abstract description 33
- 239000003381 stabilizer Substances 0.000 claims abstract description 22
- 239000004902 Softening Agent Substances 0.000 claims abstract description 9
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 34
- -1 aminopropyl Chemical group 0.000 claims description 31
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 22
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 22
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 22
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 22
- 239000000230 xanthan gum Substances 0.000 claims description 22
- 229920001285 xanthan gum Polymers 0.000 claims description 22
- 235000010493 xanthan gum Nutrition 0.000 claims description 22
- 229940082509 xanthan gum Drugs 0.000 claims description 22
- 239000004909 Moisturizer Substances 0.000 claims description 20
- 230000001333 moisturizer Effects 0.000 claims description 20
- 239000002280 amphoteric surfactant Substances 0.000 claims description 18
- 229960003237 betaine Drugs 0.000 claims description 17
- LOQGSOTUHASIHI-UHFFFAOYSA-N perfluoro-1,3-dimethylcyclohexane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(C(F)(F)F)C1(F)F LOQGSOTUHASIHI-UHFFFAOYSA-N 0.000 claims description 17
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 16
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 16
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 16
- 229960004624 perflexane Drugs 0.000 claims description 15
- 229950011087 perflunafene Drugs 0.000 claims description 15
- UWEYRJFJVCLAGH-IJWZVTFUSA-N perfluorodecalin Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)[C@@]2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C@@]21F UWEYRJFJVCLAGH-IJWZVTFUSA-N 0.000 claims description 15
- ZJIJAJXFLBMLCK-UHFFFAOYSA-N perfluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZJIJAJXFLBMLCK-UHFFFAOYSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 10
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 9
- 239000003945 anionic surfactant Substances 0.000 claims description 9
- 239000003963 antioxidant agent Substances 0.000 claims description 9
- 239000002738 chelating agent Substances 0.000 claims description 9
- 235000013922 glutamic acid Nutrition 0.000 claims description 9
- 239000004220 glutamic acid Substances 0.000 claims description 9
- 150000004676 glycans Chemical class 0.000 claims description 9
- 229920001282 polysaccharide Polymers 0.000 claims description 9
- 239000005017 polysaccharide Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- 239000002736 nonionic surfactant Substances 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 239000004064 cosurfactant Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 claims description 4
- 229940096501 sodium cocoamphoacetate Drugs 0.000 claims description 4
- 238000006467 substitution reaction Methods 0.000 claims description 4
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 claims description 3
- 229940117986 sulfobetaine Drugs 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000000686 essence Substances 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- GNMCGMFNBARSIY-UHFFFAOYSA-N 1,2,3,4,4a,4b,5,6,7,8,8a,9,10,10a-tetradecahydrophenanthrene Chemical compound C1CCCC2C3CCCCC3CCC21 GNMCGMFNBARSIY-UHFFFAOYSA-N 0.000 claims 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 1
- BKDZVPVJIXZYBH-UHFFFAOYSA-N [Na].C(C)(=O)O.NC(=N)N Chemical compound [Na].C(C)(=O)O.NC(=N)N BKDZVPVJIXZYBH-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 238000000280 densification Methods 0.000 claims 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 239000004519 grease Substances 0.000 claims 1
- OCEBOBGSOQRMQZ-UHFFFAOYSA-N trifluoromethylcyclopentane Chemical compound FC(F)(F)C1CCCC1 OCEBOBGSOQRMQZ-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 41
- 238000004140 cleaning Methods 0.000 abstract description 10
- 230000003020 moisturizing effect Effects 0.000 abstract description 6
- 229920000832 Cutin Polymers 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract description 2
- 230000002500 effect on skin Effects 0.000 abstract 1
- 230000002045 lasting effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 239000003039 volatile agent Substances 0.000 description 56
- 238000012360 testing method Methods 0.000 description 55
- 238000002360 preparation method Methods 0.000 description 21
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 20
- 238000012216 screening Methods 0.000 description 18
- 210000004204 blood vessel Anatomy 0.000 description 15
- QKENRHXGDUPTEM-UHFFFAOYSA-N perfluorophenanthrene Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C3(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C3(F)C(F)(F)C(F)(F)C21F QKENRHXGDUPTEM-UHFFFAOYSA-N 0.000 description 14
- 229920000223 polyglycerol Chemical class 0.000 description 14
- BCNXQFASJTYKDJ-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5-nonafluoro-5-(trifluoromethyl)cyclopentane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F BCNXQFASJTYKDJ-UHFFFAOYSA-N 0.000 description 13
- 229940097941 polyglyceryl-10 laurate Drugs 0.000 description 13
- 239000002994 raw material Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 12
- GOJYXPWOUJYXJC-UHFFFAOYSA-M sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O GOJYXPWOUJYXJC-UHFFFAOYSA-M 0.000 description 12
- 210000002257 embryonic structure Anatomy 0.000 description 11
- 229940015975 1,2-hexanediol Drugs 0.000 description 10
- 229940071124 cocoyl glutamate Drugs 0.000 description 10
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 10
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 10
- 241000287828 Gallus gallus Species 0.000 description 9
- 239000013543 active substance Substances 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 7
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 7
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 7
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 6
- 229920000742 Cotton Polymers 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 239000004872 foam stabilizing agent Substances 0.000 description 6
- 230000007794 irritation Effects 0.000 description 6
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 5
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 5
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 5
- 229920000570 polyether Polymers 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 4
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 4
- 229920001774 Perfluoroether Polymers 0.000 description 4
- 229940073499 decyl glucoside Drugs 0.000 description 4
- 230000000087 stabilizing effect Effects 0.000 description 4
- 238000009941 weaving Methods 0.000 description 4
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000004721 Polyphenylene oxide Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 3
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000002979 fabric softener Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 150000002462 imidazolines Chemical class 0.000 description 3
- 229940071085 lauroyl glutamate Drugs 0.000 description 3
- 230000005923 long-lasting effect Effects 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- SUZKAIPUWCLPCH-UHFFFAOYSA-N 2-[dimethyl-[3-(octanoylamino)propyl]azaniumyl]acetate Chemical compound CCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O SUZKAIPUWCLPCH-UHFFFAOYSA-N 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000005282 brightening Methods 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical group 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 229940070765 laurate Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000003966 vascular damage Effects 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005599 alkyl carboxylate group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 231100000693 bioaccumulation Toxicity 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- YYKWXZYVDGWGSF-UHFFFAOYSA-N fluoromethylcyclopentane Chemical compound FCC1CCCC1 YYKWXZYVDGWGSF-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 229940116335 lauramide Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- MEXQWQLMJYIYPG-UHFFFAOYSA-M potassium;2-oxopyrrolidine-1-carboxylate Chemical compound [K+].[O-]C(=O)N1CCCC1=O MEXQWQLMJYIYPG-UHFFFAOYSA-M 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- IPYKAMBNXWKFTC-KVVVOXFISA-M sodium;2-[2-hydroxyethyl-[2-[[(z)-octadec-9-enoyl]amino]ethyl]amino]acetate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC(=O)NCCN(CCO)CC([O-])=O IPYKAMBNXWKFTC-KVVVOXFISA-M 0.000 description 1
- LADXKQRVAFSPTR-UHFFFAOYSA-M sodium;2-hydroxyethanesulfonate Chemical compound [Na+].OCCS([O-])(=O)=O LADXKQRVAFSPTR-UHFFFAOYSA-M 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- TYLSDQJYPYQCRK-UHFFFAOYSA-N sulfo 4-amino-4-oxobutanoate Chemical compound NC(=O)CCC(=O)OS(O)(=O)=O TYLSDQJYPYQCRK-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
- A61K8/315—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域technical field
本发明涉及化妆品技术领域,尤其涉及一种发泡贴片面膜。The invention relates to the technical field of cosmetics, in particular to a foaming sheet mask.
背景技术Background technique
贴片面膜是受消费者喜爱的流行化妆品,已经融入消费者护肤的基础流程。贴片面膜通常由3部分组成,即面膜液、面膜布和包装袋。面膜液是实现面膜各种功效的基础,面膜布承载容纳面膜液辅助面膜达成期望的护肤效果,包装袋则是安全存放面膜液和面膜布所必需的。Sheet masks are popular cosmetics that are popular among consumers and have been integrated into the basic process of consumers' skin care. The sheet mask usually consists of 3 parts, namely mask liquid, mask cloth and packaging bag. The mask liquid is the basis for realizing various functions of the mask. The mask cloth carries and holds the mask liquid to assist the mask to achieve the desired skin care effect, and the packaging bag is necessary for safe storage of the mask liquid and mask cloth.
贴片面膜可以提供多样化的护肤效果,化妆品市场上消费者对贴片面膜宣称的关注点有补水、保湿、亮白、滋润、紧致、控油等,不一而足。帮助消费者实现美丽梦想,提供安全有效、带来新奇使用体验的化妆品一直是化妆品开发者的工作目标。Sheet masks can provide a variety of skin care effects. Consumers in the cosmetics market claim to pay attention to sheet masks such as hydration, moisturizing, brightening, moisturizing, firming, oil control, etc., to name a few. It has always been the goal of cosmetics developers to help consumers realize their beauty dreams and provide safe, effective and novel cosmetics.
发泡贴片面膜是一种能够产生自发泡沫、有清洁、按摩、保湿、亮白等多重效果的面膜产品。不同于普通贴片面膜产品,发泡贴片面膜产品具有洁肤、更新角质的功效。为符合消费者对贴片面膜的使用习惯,发泡贴片面膜需要在皮肤上停留15分钟左右。这种情况下,既需要考虑泡沫的密度、持久性,又要考虑产品的安全性。贴片面膜封闭皮肤的时间远长于通常洁面需要的时间,封闭条件下长时间接触表面活性剂将会给肌肤带来巨大压力。Foaming sheet mask is a mask product that can produce spontaneous foam and has multiple effects such as cleaning, massaging, moisturizing, and brightening. Different from ordinary sheet mask products, foam sheet mask products have the effect of cleansing and renewing cuticles. In order to meet consumers' habits of using sheet masks, foaming sheet masks need to stay on the skin for about 15 minutes. In this case, it is necessary to consider not only the density and durability of the foam, but also the safety of the product. The time for the sheet mask to seal the skin is much longer than the time required for usual cleansing. Prolonged contact with surfactants under closed conditions will bring great pressure to the skin.
发明内容Contents of the invention
为解决上述现有技术中存在的缺点和不足,本发明的目的在于提供一种泡沫细腻丰厚持久、清洁力度好、肤感温和舒适的发泡贴片面膜。In order to solve the shortcomings and deficiencies in the above-mentioned prior art, the object of the present invention is to provide a foaming sheet mask with fine and thick foam, good cleaning power, and mild and comfortable skin feeling.
为实现其目的,本发明采取的技术方案为:For realizing its purpose, the technical scheme that the present invention takes is:
一种发泡贴片面膜,其包括面膜布和面膜液,所述面膜液包括如下重量百分比的组分:表面活性剂0.5%~5%、挥发剂0.5%~5%、增稠稳泡剂0.2%~1%和面膜布柔软剂0.01%~0.2%。A foaming sheet mask, which includes a mask cloth and a mask liquid, and the mask liquid includes the following components in percentage by weight: 0.5% to 5% of a surfactant, 0.5% to 5% of a volatile agent, a thickening and foam stabilizing agent 0.2% to 1% and mask fabric softener 0.01% to 0.2%.
优选地,所述面膜液包括如下重量百分比的组分:表面活性剂0.7%~3%、挥发剂1%~3%、增稠稳泡剂0.2%~0.8%和面膜布柔软剂0.01%~0.1%。Preferably, the mask liquid includes the following components in weight percentage: 0.7% to 3% of surfactant, 1% to 3% of volatile agent, 0.2% to 0.8% of thickening foam stabilizer and 0.01% to 0.01% of mask cloth softener 0.1%.
优选地,所述表面活性剂包括主表面活性剂和辅助表面活性剂,所述主表面活性剂为阴离子表面活性剂,所述辅助表面活性剂包括两性表面活性剂和/或非离子表面活性剂。Preferably, the surfactant includes a main surfactant and a cosurfactant, the main surfactant is an anionic surfactant, and the cosurfactant includes an amphoteric surfactant and/or a nonionic surfactant .
优选地,所述阴离子表面活性剂包括月桂酰基谷氨酸TEA盐和椰油酰基谷氨酸TEA盐中的至少一种。优选地,所述两性表面活性剂包括辛酰/癸酰氨丙基甜菜碱、月桂酰胺丙基羟磺基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱、月桂酰两性基乙酸钠、椰油酰两性基乙酸钠中的至少一种。所述非离子表面活性剂优选为聚甘油-10月桂酸酯。本发明采用的聚甘油-10月桂酸酯,其商品名为Sunsoft Q-12Y-C,生产商为Taiyo Kagaku。上述表面活性剂是本发明通过大量创造性实验筛选出的符合本发明使用要求的表面活性剂,刺激性低,能在封闭条件下与皮肤长时间接触,与本发明面膜液其它组分的配伍性好,稳定性佳。Preferably, the anionic surfactant includes at least one of lauroyl glutamate TEA and cocoyl glutamate TEA. Preferably, the amphoteric surfactants include capryloyl/capricamidopropyl betaine, lauryl amidopropyl hydroxy sultaine, cocamidopropyl hydroxy sultaine, sodium lauroamphoacetate, coconut at least one of sodium oleoamphoacetate. The nonionic surfactant is preferably polyglyceryl-10 laurate. The polyglycerol-10 laurate that the present invention adopts has a trade name of Sunsoft Q-12Y-C, and its manufacturer is Taiyo Kagaku. The above-mentioned surfactant is a surfactant selected by the present invention through a large number of creative experiments and meets the requirements of the present invention. It has low irritation and can be in contact with the skin for a long time under closed conditions. The compatibility with other components of the facial mask liquid of the present invention OK, good stability.
优选地,所述主表面活性剂与所述辅助表面活性剂的质量比为1:1~1:3。所述主表面活性剂和辅助表面活性剂以该配比复配时,本发明的发泡贴片面膜在清洁效果、发泡效果和刺激性三方面均能达到较好的平衡,发泡和清洁效果较理想,刺激性较低。Preferably, the mass ratio of the main surfactant to the co-surfactant is 1:1˜1:3. When the main surfactant and the auxiliary surfactant are compounded in this proportion, the foaming sheet mask of the present invention can achieve a good balance in cleaning effect, foaming effect and irritation. The cleaning effect is ideal and the irritation is low.
优选地,所述挥发剂包括氟烃(perfluorocarbon)、氟醚、聚二甲基硅氧烷中的至少一种。从挥发剂的气味考虑,本发明更优选的挥发剂为氟烃、氟醚中的至少一种。从兼顾气味和安全性的角度考虑,本发明最优选的挥发剂为氟烃;氟烃是惰性的,可快速排出体外,没有生物累积性。Preferably, the volatile agent includes at least one of perfluorocarbon, fluoroether and polydimethylsiloxane. Considering the smell of the volatile agent, the more preferred volatile agent in the present invention is at least one of fluorocarbons and fluoroethers. Considering both odor and safety, the most preferred volatile agent in the present invention is fluorocarbon; fluorocarbon is inert, can be quickly excreted from the body, and has no bioaccumulation.
优选地,所述挥发剂由全氟二甲基环己烷、全氟甲基环戊烷、全氟萘烷、全氟全氢化菲和全氟己烷组成。优选地,所述全氟二甲基环己烷、全氟甲基环戊烷、全氟萘烷、全氟全氢化菲和全氟己烷的质量比为1:1~10:2~15:3~25:11~65,此时,面膜液的发泡效果较优。最优选地,所述全氟二甲基环己烷、全氟甲基环戊烷、全氟萘烷、全氟全氢化菲和全氟己烷的质量比为1:3:6:10:30,此时,面膜液的发泡效果最好,可以展现出快速和持久的发泡效果。Preferably, the volatile agent consists of perfluorodimethylcyclohexane, perfluoromethylcyclopentane, perfluorodecalin, perfluoroperhydrophenanthrene and perfluorohexane. Preferably, the mass ratio of perfluorodimethylcyclohexane, perfluoromethylcyclopentane, perfluorodecalin, perfluoroperhydrophenanthrene and perfluorohexane is 1:1-10:2-15 : 3~25: 11~65, at this time, the foaming effect of the mask liquid is better. Most preferably, the mass ratio of the perfluorodimethylcyclohexane, perfluoromethylcyclopentane, perfluorodecalin, perfluoroperhydrophenanthrene and perfluorohexane is 1:3:6:10: 30. At this time, the foaming effect of the mask liquid is the best, and it can show a fast and long-lasting foaming effect.
优选地,所述表面活性剂与所述挥发剂的质量比为1:1~1:2。此时,本发明面膜具有较好的发泡效果,清洁能力佳,温和性高,且生产成本较低。Preferably, the mass ratio of the surfactant to the volatile agent is 1:1˜1:2. At this time, the facial mask of the present invention has good foaming effect, good cleaning ability, high mildness, and low production cost.
优选地,所述增稠稳泡剂包括丙烯酸酯聚合物、天然多糖及其衍生物中的至少一种。从发泡贴片面膜的使用贴服性和舒适性,以及本发明配方中各组分的配伍性考虑,更优选地,所述增稠稳泡剂为天然多糖及其衍生物。优选地,所述增稠稳泡剂为黄原胶和羟丙基甲基纤维素。优选地,所述黄原胶与羟丙基甲基纤维素的质量比为2:1~1:1,此时,面膜液的综合效果较好,增稠效果、稳泡效果和肤感之间获得平衡。Preferably, the thickening and foam stabilizing agent includes at least one of acrylate polymers, natural polysaccharides and derivatives thereof. In view of the fit and comfort of the foaming sheet mask, and the compatibility of the components in the formula of the present invention, more preferably, the thickening and foam stabilizing agent is a natural polysaccharide and its derivatives. Preferably, the thickening foam stabilizer is xanthan gum and hydroxypropyl methylcellulose. Preferably, the mass ratio of xanthan gum to hydroxypropyl methylcellulose is 2:1 to 1:1. At this time, the comprehensive effect of the facial mask liquid is better, and the combination of thickening effect, foam stabilizing effect and skin feel balance between.
优选地,所述面膜布柔软剂包括天然多糖及其衍生物中的至少一种。Preferably, the facial mask cloth softener includes at least one of natural polysaccharides and derivatives thereof.
更优选地,所述面膜布柔软剂为羟乙基纤维素。优选地,所述羟乙基纤维素的1%粘度范围3000mPa·s~6000mPa·s,摩尔取代比为2.5。所述羟乙基纤维素可以改善面膜布的柔软性和贴服性,改善中等和加厚型面膜布以及交叉铺网织法且编织较均匀的薄型面膜布的延展性,以更好地适应不同脸型的消费者。More preferably, the facial mask cloth softener is hydroxyethyl cellulose. Preferably, the 1% viscosity of the hydroxyethyl cellulose ranges from 3000 mPa·s to 6000 mPa·s, and the molar substitution ratio is 2.5. The hydroxyethyl cellulose can improve the softness and fitability of the mask cloth, improve the extensibility of the medium and thick mask cloth and the thin mask cloth with cross-lapping weave and weave more evenly, so as to better adapt to Consumers with different faces.
优选地,所述面膜液还包括辅料。优选地,所述辅料包括防腐剂、螯合剂、香精、油脂、保湿剂、增溶剂、着色剂、抗氧化剂和肤感调节剂中的至少一种。优选地,所述防腐剂选自甲醛释放剂、尼泊金酯、含卤素化合物、季铵盐、有机酸和醇中的至少一种。更优选地,所述防腐剂为有机酸类防腐剂或者醇类防腐剂。优选地,所述螯合剂为EDTA二钠。优选地,所述保湿剂为甘油、丙二醇、丁二醇、1,2-戊二醇、1,2-己二醇、双甘油、双丙甘醇、吡咯烷酮羧酸钠、吡咯烷酮羧酸钾、透明质酸钠、糖和聚乙二醇中的至少一种。优选地,所述抗氧化剂为生育酚(维生素E)、生育酚乙酸酯、丁羟甲苯和对羟基苯乙酮中的至少一种。Preferably, the facial mask liquid also includes auxiliary materials. Preferably, the auxiliary materials include at least one of preservatives, chelating agents, essences, oils, moisturizers, solubilizers, colorants, antioxidants and skin feel regulators. Preferably, the preservative is at least one selected from formaldehyde releasing agents, parabens, halogen-containing compounds, quaternary ammonium salts, organic acids and alcohols. More preferably, the preservative is an organic acid preservative or an alcohol preservative. Preferably, the chelating agent is disodium EDTA. Preferably, the moisturizing agent is glycerin, propylene glycol, butylene glycol, 1,2-pentanediol, 1,2-hexanediol, diglycerin, dipropylene glycol, sodium pyrrolidone carboxylate, potassium pyrrolidone carboxylate, At least one of sodium hyaluronate, sugar and polyethylene glycol. Preferably, the antioxidant is at least one of tocopherol (vitamin E), tocopheryl acetate, butylated hydroxytoluene and p-hydroxyacetophenone.
优选地,所述面膜布为植物纤维、化学纤维中的至少一种。更优选地,所述面膜布为非网眼的致密单向铺网织法或交叉铺网织法。Preferably, the mask cloth is at least one of plant fiber and chemical fiber. More preferably, the mask cloth is a non-mesh dense unidirectional weave or cross-laid weave.
优选地,所述面膜液由如下重量百分比的组分组成:黄原胶0.35%、羟丙基甲基纤维素0.3%、羟乙基纤维素0.05%、双丙甘醇1%、1,3-丙二醇1%、1,2-己二醇0.4%、对羟基苯乙酮0.5%、EDTA二钠0.05%、聚甘油-10月桂酸酯0.67%、椰油酰基谷氨酸TEA盐0.67%、月桂酰两性基乙酸钠0.67%、全氟二甲基环己烷0.06%、全氟甲基环戊烷0.18%、全氟萘烷0.36%、全氟全氢化菲0.6%、全氟己烷1.8%、以及水余量。Preferably, the mask liquid is composed of the following components by weight percentage: 0.35% xanthan gum, 0.3% hydroxypropyl methylcellulose, 0.05% hydroxyethyl cellulose, 1% dipropylene glycol, 1,3 -Propylene glycol 1%, 1,2-hexanediol 0.4%, p-hydroxyacetophenone 0.5%, EDTA disodium 0.05%, polyglyceryl-10 laurate 0.67%, cocoyl glutamic acid TEA salt 0.67%, Sodium lauroamphoacetate 0.67%, Perfluorodimethylcyclohexane 0.06%, Perfluoromethylcyclopentane 0.18%, Perfluorodecalin 0.36%, Perfluoroperhydrophenanthrene 0.6%, Perfluorohexane 1.8 %, and the water balance.
优选地,所述面膜液由如下重量百分比的组分组成:黄原胶0.35%、羟丙基甲基纤维素0.3%、羟乙基纤维素0.05%、双丙甘醇1%、1,3-丙二醇1%、1,2-己二醇0.4%、对羟基苯乙酮0.5%、EDTA二钠0.05%、聚甘油-10月桂酸酯1%、椰油酰基谷氨酸TEA盐1%、月桂酰两性基乙酸钠1%、全氟二甲基环己烷0.06%、全氟甲基环戊烷0.18%、全氟萘烷0.36%、全氟全氢化菲0.6%、全氟己烷1.8%、以及水余量。Preferably, the mask liquid is composed of the following components by weight percentage: 0.35% xanthan gum, 0.3% hydroxypropyl methylcellulose, 0.05% hydroxyethyl cellulose, 1% dipropylene glycol, 1,3 -Propylene glycol 1%, 1,2-hexanediol 0.4%, p-hydroxyacetophenone 0.5%, EDTA disodium 0.05%, polyglyceryl-10 laurate 1%, cocoyl glutamic acid TEA salt 1%, Sodium lauroamphoacetate 1%, perfluorodimethylcyclohexane 0.06%, perfluoromethylcyclopentane 0.18%, perfluorodecalin 0.36%, perfluoroperhydrophenanthrene 0.6%, perfluorohexane 1.8 %, and the water balance.
优选地,所述面膜液由如下重量百分比的组分组成:黄原胶0.35%、羟丙基甲基纤维素0.3%、羟乙基纤维素0.05%、双丙甘醇1%、1,3-丙二醇1%、1,2-己二醇0.4%、对羟基苯乙酮0.5%、EDTA二钠0.05%、聚甘油-10月桂酸酯0.1%、椰油酰基谷氨酸TEA盐0.3%、月桂酰两性基乙酸钠0.3%、全氟二甲基环己烷0.02%、全氟甲基环戊烷0.06%、全氟萘烷0.12%、全氟全氢化菲0.2%、全氟己烷0.6%、以及水余量。Preferably, the mask liquid is composed of the following components by weight percentage: 0.35% xanthan gum, 0.3% hydroxypropyl methylcellulose, 0.05% hydroxyethylcellulose, 1% dipropylene glycol, 1,3 -Propylene glycol 1%, 1,2-hexanediol 0.4%, p-hydroxyacetophenone 0.5%, EDTA disodium 0.05%, polyglyceryl-10 laurate 0.1%, cocoyl glutamic acid TEA salt 0.3%, Sodium lauroamphoacetate 0.3%, perfluorodimethylcyclohexane 0.02%, perfluoromethylcyclopentane 0.06%, perfluorodecalin 0.12%, perfluoroperhydrophenanthrene 0.2%, perfluorohexane 0.6 %, and the water balance.
与现有技术相比,本发明的有益效果为:本发明的发泡贴片面膜安全无刺激,能长时间敷于面部,既具有护肤美容功效,又具有洁肤效果,能赋予消费者多层次的体验感,及满足消费者多方面的护肤需求。本发明的发泡贴片面膜肤感舒适温和,产生的泡沫丰富、细腻而持久,对皮肤的清洁效果好,还能清除老化角质,保湿滋润肌肤,提亮肤色,用后令皮肤光滑、水润、白皙、富有光泽。Compared with the prior art, the beneficial effects of the present invention are: the foaming sheet mask of the present invention is safe and non-irritating, can be applied to the face for a long time, has both skin care and beauty effects, and has skin cleansing effects, and can give consumers more Layered sense of experience, and to meet the various skin care needs of consumers. The foam patch mask of the present invention has a comfortable and gentle skin feeling, produces rich, delicate and long-lasting foam, has a good cleaning effect on the skin, can also remove aging cutin, moisturize the skin, brighten the complexion, and make the skin smooth and hydrated after use. Moist, fair and lustrous.
附图说明Description of drawings
图1为实施例1中2%椰油酰基谷氨酸TEA盐的CAMVA试验结果;Fig. 1 is the CAMVA test result of 2% cocoyl glutamic acid TEA salt among the embodiment 1;
图2为实施例1中2%辛酰/癸酰氨丙基甜菜碱的CAMVA试验结果;Fig. 2 is the CAMVA test result of 2% octanoyl/capricamidopropyl betaine in embodiment 1;
图3为实施例1中2%月桂酰胺丙基甜菜碱的CAMVA试验结果;Fig. 3 is the CAMVA test result of 2% lauryl amidopropyl betaine in embodiment 1;
图4为实施例1中2%椰油酰胺丙基甜菜碱的CAMVA试验结果;Fig. 4 is the CAMVA test result of 2% cocamidopropyl betaine in embodiment 1;
图5为实施例1中2%月桂酰胺丙基羟磺基甜菜碱的CAMVA试验结果;Fig. 5 is the CAMVA test result of 2% lauramide propyl hydroxy sultaine in embodiment 1;
图6为实施例1中2%椰油酰胺丙基羟基磺基甜菜碱的CAMVA试验结果;Fig. 6 is the CAMVA test result of 2% cocamidopropyl hydroxy sultaine in embodiment 1;
图7为实施例1中2%月桂酰两性基乙酸钠的CAMVA试验结果;Fig. 7 is the CAMVA test result of 2% sodium lauroamphoacetate in embodiment 1;
图8为实施例1中2%椰油酰两性基乙酸钠的CAMVA试验结果;Fig. 8 is the CAMVA test result of 2% sodium cocoamphoacetate in embodiment 1;
图9为实施例1中2%癸基葡糖苷的CAMVA试验结果;Fig. 9 is the CAMVA test result of 2% decyl glucoside in embodiment 1;
图10为实施例1中2%S Face L-1001的CAMVA试验结果;Fig. 10 is the CAMVA test result of 2% S Face L-1001 in embodiment 1;
图11为实施例1中2%S Face 10G L的CAMVA试验结果;Fig. 11 is the CAMVA test result of 2% S Face 10GL in embodiment 1;
图12为实施例1中2%PGLE ML10的CAMVA试验结果;Fig. 12 is the CAMVA test result of 2% PGLE ML10 in embodiment 1;
图13为实施例1中2%Sunsoft Q-12Y-C的CAMVA试验结果;Fig. 13 is the CAMVA test result of 2% Sunsoft Q-12Y-C in embodiment 1;
图14为实施例4中表面活性剂和挥发剂的质量比筛选的实验结果;Fig. 14 is the experimental result of the mass ratio screening of surfactant and volatile agent in embodiment 4;
图15为实施例6中面膜布的筛选实验结果;Fig. 15 is the screening test result of mask cloth in embodiment 6;
图16为实施例6中面膜布的筛选实验结果。Fig. 16 is the screening test result of mask cloth in embodiment 6.
具体实施方式Detailed ways
为更好的说明本发明的目的、技术方案和优点,本发明通过下列实施例进一步说明。应理解,本发明实施例仅用于说明本发明的技术效果,而非用于限制本发明的保护范围。实施例中,所用方法如无特别说明,均为常规方法。同时,实施例中,所用的材料、试剂等,如无特殊说明,均可从商业途径得到。In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention is further illustrated by the following examples. It should be understood that the embodiments of the present invention are only used to illustrate the technical effect of the present invention, and are not used to limit the protection scope of the present invention. In the examples, the methods used are conventional methods unless otherwise specified. Meanwhile, in the examples, the materials and reagents used can be obtained from commercial sources unless otherwise specified.
本发明使用CAMVA鸡胚绒毛尿囊膜试验进行原料和配方的刺激性测试和评价。CAMVA的基本原理是利用孵化10到14天的受精蛋胚(鸡胚、鸭胚、鹅胚等易于培养观察的受精胚)中期绒毛尿囊膜(CAM)血管与人眼结膜血管组成较为相似的特征,通过将刺激物定向性的刺激CAM血管,观察血管及其周边组织变化,模拟待测刺激物对人眼结膜血管的刺激损伤,并根据CAM上的血管损伤程度给予刺激度评分,最终确定产品的刺激值范围。CAMVA评分标准如下表1。The invention uses the CAMVA chicken embryo chorioallantoic membrane test to carry out the irritation test and evaluation of raw materials and formulas. The basic principle of CAMVA is to use the chorioallantoic membrane (CAM) blood vessels in the fertilized egg embryos (chicken embryos, duck embryos, goose embryos and other fertilized embryos that are easy to culture and observe) that have been incubated for 10 to 14 days to have a composition similar to that of human conjunctival blood vessels. Features, by directional stimulation of CAM blood vessels with stimulants, observing the changes in blood vessels and their surrounding tissues, simulating the stimulation damage of human conjunctival blood vessels by the stimulants to be tested, and giving a stimulation score according to the degree of vascular damage on the CAM, the final determination The stimulus value range of the product. The CAMVA scoring criteria are shown in Table 1 below.
表1评分标准Table 1 Scoring Criteria
注释:Notes:
1.鬼影血管:指血管内无血液灌注的血管1. Ghost blood vessels: refer to blood vessels without blood perfusion in the blood vessels
2.充血:指血管内血液不流动或血管胀所致的血液充盈现象2. Congestion: Refers to the phenomenon of blood filling caused by stagnant blood flow in blood vessels or blood vessel swelling
3.出血:血液从血管内流出血管外,可以表现为血管外出现点状出血或絮状的弥漫性出血等多种形式,按照测试环内反应打分。3. Bleeding: blood flows out of the blood vessel from the blood vessel, which can appear in various forms such as spotting or flocculent diffuse bleeding outside the blood vessel, and is scored according to the reaction in the test circle.
根据血管损伤程度评分的平均大小(即NC值)来比较受试物的刺激大小,评价标准如下表2。According to the average size (ie NC value) of the vascular damage score, the stimulus size of the test substance is compared, and the evaluation criteria are shown in Table 2 below.
表2评价标准Table 2 Evaluation Criteria
本发明刺激性替代试验使用SPF级白莱杭鸡(White Leghom chicken)受精鸡胚,孵化10天,开壳暴露CAM膜放置O形环,将不同受试物直接加于环内,37℃孵育30分钟后观察拍照记录血管变化,观察统计阳性反应(充血、鬼影血管、出血等)鸡胚数。0.9%生理盐水作为阴性对照,每批SPF级受精鸡胚测试3个鸡胚。受试物测试10个受精鸡胚,去掉1个最高评分和1个最低评分,计算剩余8个受精鸡胚评分的平均值,即得出该受试物NC值。根据市场实践经验,面贴膜的面膜液的NC值应该是≤3,这样的面膜液刺激性才有好的市场接受度。本发明评价发泡贴片面膜的温和性即采用此经验值作为评判标准。The irritation substitution test of the present invention uses SPF grade White Leghom chicken fertilized chicken embryos, hatches for 10 days, opens the shell to expose the CAM membrane and places an O-ring, directly adds different test substances into the ring, and incubates at 37°C After 30 minutes, observe and take pictures to record the changes in blood vessels, observe and count the number of chicken embryos with positive reactions (congestion, ghost blood vessels, bleeding, etc.). 0.9% normal saline was used as a negative control, and 3 chicken embryos were tested for each batch of SPF grade fertilized chicken embryos. The test substance was tested on 10 fertilized chicken embryos, one highest score and one lowest score were removed, and the average score of the remaining 8 fertilized chicken embryos was calculated to obtain the NC value of the test substance. According to the practical experience in the market, the NC value of the facial mask liquid should be ≤3, so that the irritating effect of such a facial mask liquid has a good market acceptance. The present invention evaluates the mildness of the foaming sheet mask and adopts this empirical value as the criterion.
实施例1表面活性剂的筛选The screening of embodiment 1 surfactant
一、阴离子表面活性剂的筛选1. Screening of anionic surfactants
本发明使用的阴离子表面活性剂可选自烷基硫酸酯盐、烷基聚醚硫酸盐、羟乙磺酸酯钠盐、烷基磺基琥珀酸酯盐、烷基聚醚磺基琥珀酸酯盐、烷基酰胺基磺基琥珀酰胺酸酯盐、烷基磷酸酯盐、烷基羧酸盐、烷基聚醚羧酸盐、酰基氨基酸盐、酰基肌氨酸盐、酰基牛磺酸盐中的至少一种。但作为贴片面膜中使用的阴离子表面活性剂,应着重考虑其温和性和接近皮肤pH值5~7范围的溶解性,还要考虑市场的喜好。经过筛选,优选的阴离子表面活性剂是酰基氨基酸盐,更为优选的阴离子表面活性剂是月桂酰基谷氨酸TEA盐和椰油酰基谷氨酸TEA盐中的至少一种。经试验测试,椰油酰基谷氨酸TEA盐2%活性物的CAMVA试验结果如图1所示。The anionic surfactant used in the present invention can be selected from alkyl sulfate ester salt, alkyl polyether sulfate salt, isethionate sodium salt, alkyl sulfosuccinate salt, alkyl polyether sulfosuccinate salt, alkyl amido sulfosuccinamate, alkyl phosphate, alkyl carboxylate, alkyl polyether carboxylate, acyl amino acid salt, acyl sarcosinate, acyl taurate at least one of . However, as an anionic surfactant used in sheet masks, its mildness and solubility close to the skin pH range of 5 to 7 should be considered, and market preferences should also be considered. After screening, the preferred anionic surfactant is acyl amino acid salt, and the more preferred anionic surfactant is at least one of lauroyl glutamic acid TEA salt and cocoyl glutamic acid TEA salt. After testing, the CAMVA test results of 2% active substance of cocoyl glutamate TEA salt are shown in FIG. 1 .
椰油酰基谷氨酸TEA盐2%活性物的CAMVA试验的NC值如下表3。The NC values of the CAMVA test of cocoyl glutamic acid TEA salt 2% active matter are shown in Table 3 below.
表3 2%椰油酰基谷氨酸TEA盐CAMVA试验的NC值Table 3 NC value of 2% cocoyl glutamate TEA salt CAMVA test
从表3可看出,2%椰油酰基谷氨酸TEA盐的NC值为2.375,适合做本发明的表面活性剂。As can be seen from Table 3, the NC value of 2% cocoyl glutamic acid TEA salt is 2.375, which is suitable for the surfactant of the present invention.
月桂酰基谷氨酸TEA盐的结构与椰油酰基谷氨酸TEA盐相近,而且由于脂肪酸链的差别,月桂酰基谷氨酸TEA盐的水溶性比椰油酰基谷氨酸TEA盐的水溶性更好。本发明对月桂酰基谷氨酸TEA盐也进行了CAMVA试验,其NC值与椰油酰基谷氨酸TEA盐的NC值接近且小于3,也适合做本发明的表面活性剂。The structure of lauroyl glutamate TEA salt is similar to that of cocoyl glutamate TEA salt, and due to the difference in the fatty acid chain, the water solubility of lauroyl glutamate TEA salt is more water-soluble than that of cocoyl glutamate TEA salt. it is good. The present invention has also carried out CAMVA test to lauroyl glutamic acid TEA salt, and its NC value is close to the NC value of cocoyl glutamic acid TEA salt and is less than 3, is also suitable as surfactant of the present invention.
本发明中使用的两性表面活性剂选自羧酸甜菜碱两性表面活性剂、磺酸甜菜碱两性表面活性剂、硫酸酯甜菜碱两性表面活性剂、烷基酰胺磷酸酯甜菜碱两性表面活性剂、烷基两性乙酸盐、烷基两性丙酸盐中的至少一种。优选的两性表面活性剂为甜菜碱类和咪唑啉类的至少一种。CAMVA试验受试的甜菜碱类和咪唑啉类两性表面活性剂结果如图2~8所示,其中,图2为2%辛酰/癸酰氨丙基甜菜碱的CAMVA试验结果,图3为2%月桂酰胺丙基甜菜碱的CAMVA试验结果,图4为2%椰油酰胺丙基甜菜碱的CAMVA试验结果,图5为2%月桂酰胺丙基羟磺基甜菜碱的CAMVA试验结果,图6为2%椰油酰胺丙基羟基磺基甜菜碱的CAMVA试验结果,图7为2%月桂酰两性基乙酸钠的CAMVA试验结果,图8为2%椰油酰两性基乙酸钠的CAMVA试验结果。The amphoteric surfactant used in the present invention is selected from carboxylate betaine amphoteric surfactant, sulfonate betaine amphoteric surfactant, sulfate betaine amphoteric surfactant, alkylamide phosphate betaine amphoteric surfactant, At least one of alkyl amphoacetate and alkyl amphopropionate. Preferred amphoteric surfactants are at least one of betaines and imidazolines. The results of the betaine and imidazoline amphoteric surfactants tested in the CAMVA test are shown in Figures 2 to 8, wherein Figure 2 is the CAMVA test result of 2% octanoyl/capricamidopropyl betaine, and Figure 3 is The CAMVA test result of 2% lauryl amidopropyl betaine, Fig. 4 is the CAMVA test result of 2% cocamidopropyl betaine, Fig. 5 is the CAMVA test result of 2% lauryl amidopropyl hydroxysultaine, Fig. 6 is the CAMVA test result of 2% cocamidopropyl hydroxy sultaine, Fig. 7 is the CAMVA test result of 2% sodium lauroamphoacetate, and Fig. 8 is the CAMVA test result of 2% sodium cocoamphoacetate result.
受试两性表面活性剂的2%活性物CAMVA试验的NC值如下表4。The NC values of the 2% active CAMVA test of the tested amphoteric surfactants are shown in Table 4 below.
表4 2%甜菜碱类和咪唑啉类两性表面活性剂CAMVA试验的NC值Table 4 NC value of 2% betaine and imidazoline amphoteric surfactant CAMVA test
从表4可以看出,本发明上述优选的甜菜碱类和咪唑啉类两性表面活性剂的NC值均≤3,适合做本发明的表面活性剂。As can be seen from Table 4, the NC values of the above-mentioned preferred betaine and imidazoline amphoteric surfactants of the present invention are all ≤ 3, and are suitable as surfactants of the present invention.
更进一步的配方配伍性实验可以选择出更优选的两性表面活性剂,实验配方如表5。Further formulation compatibility experiments can select more preferred amphoteric surfactants, and the experimental formulations are shown in Table 5.
表5优选的甜菜碱类和咪唑啉类两性表面活性剂配伍性实验配方Table 5 preferred betaine and imidazoline amphoteric surfactant compatibility test formula
制备工艺如下:The preparation process is as follows:
1、将序号1~7的原料混合,搅拌均匀后加入序号8~9的原料,搅拌加热,80~85℃下保温30min;1. Mix the raw materials of serial number 1-7, stir evenly, add the raw materials of serial number 8-9, stir and heat, and keep warm at 80-85°C for 30 minutes;
2、加入序号10~12的原料,搅拌,冷却降温,降至35℃时加入序号13~17的原料,搅拌均匀;2. Add the raw materials with serial numbers 10-12, stir, cool down, add the raw materials with serial numbers 13-17 when the temperature drops to 35°C, and stir evenly;
3、抽样检查,合格过滤出料,料液搅拌罐装。3. Sampling inspection, qualified filter discharge, material liquid stirring tank.
将含上述优选的甜菜碱类和咪唑啉类两性表面活性剂的发泡贴片面膜的面膜液进行超常规稳定性测试,1天和28天取出,恢复室温观察外观变化。结果见下表6和表7。The facial mask liquid of the foaming sheet mask containing the above-mentioned preferred betaine-based and imidazoline-based amphoteric surfactants was subjected to an extraordinary stability test, taken out at 1 day and 28 days, and returned to room temperature to observe the change in appearance. The results are shown in Tables 6 and 7 below.
表6含优选的甜菜碱类和咪唑啉类发泡贴片面膜的面膜液1天超常规稳定性Table 6 Contains preferred betaines and imidazolines foaming sheet mask's facial mask liquid 1 day super-conventional stability
表7含优选的甜菜碱类和咪唑啉类发泡贴片面膜的面膜液28天超常规稳定性Table 7 contains preferred betaines and imidazolines foaming sheet mask of facial mask liquid 28 days of super-conventional stability
含月桂酰胺丙基甜菜碱和椰油酰胺丙基甜菜碱的发泡贴片面膜的面膜液1天超常规稳定性即出现异常,不再进行28天超常规稳定测试。The mask liquid of the foaming sheet mask containing lauryl amidopropyl betaine and cocamidopropyl betaine has abnormal stability within 1 day, and the 28-day ultra-normal stability test is no longer performed.
从表7的实验结果可以知道,含有辛酰/癸酰氨丙基甜菜碱、月桂酰胺丙基羟磺基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱、月桂酰两性基乙酸钠、椰油酰两性基乙酸钠的面膜液体系无异常,因此更优选的两性表面活性剂是辛酰/癸酰氨丙基甜菜碱、月桂酰胺丙基羟磺基甜菜碱、椰油酰胺丙基羟基磺基甜菜碱、月桂酰两性基乙酸钠、椰油酰两性基乙酸钠中至少一种。From the experimental results in Table 7, it can be known that it contains caprylyl/caprylamidopropyl betaine, lauryl amidopropyl hydroxy sultaine, cocamidopropyl hydroxy sultaine, sodium lauroamphoacetate, coconut There is no abnormality in the facial mask liquid system of sodium oleamphoacetate, so more preferred amphoteric surfactants are caprylyl/caprylamidopropyl betaine, lauryl amidopropyl hydroxy sulfobetaine, cocamidopropyl hydroxy sulfobetaine at least one of betaine, sodium lauroamphoacetate, and sodium cocoamphoacetate.
本发明中使用的非离子表面活性剂选自脂肪醇聚醚、烷基酚聚醚、烷基醇酰胺、聚乙二醇脂肪酸酯、聚甘油酯和烷基葡糖苷中的至少一种。其中,从和肌肤pH值接近的pH5~7范围的表面活性剂的溶解性、温和性和消费者喜好度考虑,优选的非离子表面活性剂为聚甘油酯,筛选实验如下。The nonionic surfactant used in the present invention is at least one selected from fatty alcohol polyethers, alkylphenol polyethers, alkanolamides, polyethylene glycol fatty acid esters, polyglycerol esters and alkyl glucosides. Among them, considering the solubility, mildness and consumer preference of surfactants in the pH5-7 range close to the pH value of the skin, the preferred nonionic surfactant is polyglycerol ester, and the screening experiment is as follows.
从水溶性考虑,烷基葡糖苷中选择癸基葡糖苷进行CAMVA试验。2%烷基葡糖苷活性物CAMVA试验的结果如图9所示,NC值见下表8。From the consideration of water solubility, decyl glucoside was selected for CAMVA test among alkyl glucosides. The results of the 2% alkyl glucoside active substance CAMVA test are shown in Figure 9, and the NC values are shown in Table 8 below.
表8 2%癸基葡糖苷CAMVA试验的NC值Table 8 NC value of 2% decyl glucoside CAMVA test
从表8可以看出,癸基葡糖苷的NC值为4.5,不适合做本发明的表面活性剂。As can be seen from Table 8, the NC value of decyl glucoside is 4.5, which is not suitable for the surfactant of the present invention.
聚甘油酯表面活性剂为聚甘油酯和脂肪酸形成的单酯。聚甘油可以有环状聚甘油、支链聚甘油和直链聚甘油等类型,这3种类型聚甘油在聚甘油中的比例由于技术和工艺的不同而不同,由此得来的聚甘油酯表面活性剂的性能也会产生不同。表9为不同厂家的的聚甘油-10月桂酸酯的HLB值和外观比较。Polyglycerol ester surfactants are monoesters formed of polyglycerol esters and fatty acids. Polyglycerol can have types such as cyclic polyglycerol, branched polyglycerol and linear polyglycerol. The proportions of these three types of polyglycerol in polyglycerol are different due to different technologies and processes. The resulting polyglycerol esters Surfactant properties can also make a difference. Table 9 compares the HLB value and appearance of polyglyceryl-10 laurate from different manufacturers.
表9不同厂家聚甘油-10月桂酸酯的外观比较Table 9 Comparison of appearance of polyglyceryl-10 laurate from different manufacturers
从外观、原料气味和水溶液的溶解性等方面考虑,选择S Face L-1001、S Face10G L、PGLE ML10和Sunsoft Q-12Y-C进行CAMVA试验,结果如图10~13所示。Considering appearance, smell of raw materials and solubility of aqueous solution, etc., S Face L-1001, S Face10G L, PGLE ML10 and Sunsoft Q-12Y-C were selected for CAMVA test. The results are shown in Figures 10-13.
受试的聚甘油-10月桂酸酯2%活性物CAMVA试验的NC值如下表10。The NC values of the tested polyglyceryl-10 laurate 2% active matter CAMVA test are shown in Table 10 below.
表10 2%受试的聚甘油-10月桂酸酯CAMVA试验的NC值Table 10 NC value of 2% tested polyglyceryl-10 laurate CAMVA test
从表10可以看出,适合本发明的更优的聚甘油-10月桂酸酯是特定类型的,尽管聚甘油酯表面活性剂是公认的温和表面活性剂,但是聚甘油的不同聚合形式影响聚甘油酯的水中溶解性和温和性。As can be seen from Table 10, the more optimal polyglycerol-10 laurate suitable for the present invention is a specific type. Although polyglycerol ester surfactants are recognized as mild surfactants, the different polymerization forms of polyglycerol affect polyglycerol. Water solubility and mildness of glycerides.
实施例2挥发剂的筛选The screening of embodiment 2 volatile agents
本发明使用的所述挥发剂选自氟烃、氟醚和聚二甲基硅氧烷中的至少一种。从原料气味考虑,排除聚二甲基硅氧烷,优选的挥发剂为氟烃和氟醚。从消费者的安全偏好角度考虑,更优选的挥发剂为氟烃。The volatile agent used in the present invention is at least one selected from fluorocarbons, fluoroethers and polydimethylsiloxanes. Considering the smell of raw materials, excluding polydimethylsiloxane, the preferred volatile agents are fluorocarbons and fluoroethers. From the standpoint of consumer safety preference, the more preferred volatile agent is fluorocarbon.
不同氟烃有不同的挥发速度,更优选的氟烃组合物在发泡贴片面膜可以展现出快速和持久的发泡效果。因此,优选地,所述选挥发剂为全氟二甲基环己烷、全氟甲基环戊烷、全氟萘烷、全氟全氢化菲和全氟己烷的组合物,且所述全氟二甲基环己烷、全氟甲基环戊烷、全氟萘烷、全氟全氢化菲和全氟己烷的质量比为1:1~10:2~15:3~25:11~65。Different fluorocarbons have different volatilization speeds, and a more preferred fluorocarbon composition can exhibit a rapid and long-lasting foaming effect in the foaming sheet mask. Therefore, preferably, the selected volatile agent is a combination of perfluorodimethylcyclohexane, perfluoromethylcyclopentane, perfluorodecalin, perfluoroperhydrophenanthrene and perfluorohexane, and the The mass ratio of perfluorodimethylcyclohexane, perfluoromethylcyclopentane, perfluorodecalin, perfluoroperhydrophenanthrene and perfluorohexane is 1:1~10:2~15:3~25: 11~65.
挥发剂为全氟二甲基环己烷、全氟甲基环戊烷、全氟萘烷、全氟全氢化菲和全氟己烷的组合物时,其在本发明发泡贴片面膜中的使用量筛选如下,挥发剂添加量分别为0.50%、1.0%、2.0%、3.0%、4.0%和5.0%,挥发剂中各组分的质量比为全氟二甲基环己烷:全氟甲基环戊烷:全氟萘烷:全氟全氢化菲:全氟己烷=1:3:6:10:30,测试配方如下表11。When the volatile agent is a composition of perfluorodimethylcyclohexane, perfluoromethylcyclopentane, perfluorodecalin, perfluoroperhydrophenanthrene and perfluorohexane, it is used in the foaming sheet mask of the present invention The amount of usage is screened as follows, the added amount of volatile agent is respectively 0.50%, 1.0%, 2.0%, 3.0%, 4.0% and 5.0%, and the mass ratio of each component in the volatile agent is perfluorodimethylcyclohexane:perfluorodimethylcyclohexane:perfluorodimethylcyclohexane: Fluoromethylcyclopentane: perfluorodecalin: perfluoroperhydrophenanthrene: perfluorohexane=1:3:6:10:30, the test formula is shown in Table 11.
表11挥发剂添加量测试配方Table 11 Test formula for volatile agent addition
制备工艺参考实施例1中表5的制备工艺。For the preparation process, refer to the preparation process in Table 5 in Example 1.
优选挥发剂组合发泡效果评价如下表12。The evaluation of the foaming effect of the preferred combination of volatile agents is shown in Table 12 below.
表12挥发剂的发泡效果评价The foaming effect evaluation of table 12 volatile agent
从表12可以看出,氟烃挥发剂的添加量达到1%时,面膜液已可获得较致密的发泡效果,添加量为3%时已可获得致密丰厚的泡沫,因此,从经济性角度考虑,本发明优选的挥发剂添加量为1%~3%。As can be seen from Table 12, when the addition amount of fluorocarbon volatile agent reaches 1%, the mask liquid can obtain a relatively dense foaming effect, and when the addition amount is 3%, dense and rich foam can be obtained. Therefore, from the perspective of economy Considering the perspective, the preferred amount of volatile agent added in the present invention is 1% to 3%.
实施例3增稠稳泡剂的筛选The screening of embodiment 3 thickening foam stabilizer
本发明使用的所述增稠稳泡剂选自丙烯酸酯聚合物、天然多糖及其衍生物的至少一种。从面膜的使用贴服舒适性和表面活性剂配伍增稠效果角度考虑,优选的天然多糖及其衍生物的至少一种。The thickening and foam stabilizing agent used in the present invention is at least one selected from acrylate polymers, natural polysaccharides and derivatives thereof. From the perspective of the comfort of wearing the mask and the thickening effect of surfactant compatibility, at least one of natural polysaccharides and derivatives thereof is preferred.
本发明更为优选增稠稳泡剂为黄原胶和羟丙基甲基纤维素的组合物,所述1%黄原胶在1%氯化钾溶液的粘度为1200cP~1800cP,所述羟丙基甲基纤维素的2%胶典型粘度为2000cP~6000cP。The more preferred thickening foam stabilizer of the present invention is the composition of xanthan gum and hydroxypropyl methylcellulose, and the viscosity of described 1% xanthan gum in 1% potassium chloride solution is 1200cP~1800cP, and described hydroxypropyl methylcellulose The typical viscosity of 2% glue of propyl methylcellulose is 2000cP~6000cP.
本发明发泡贴片面膜液优选的粘度范围是120mPa·s~250mPa·s,这样既不会因为粘度低而面膜液流淌,也不会因为粘度高而肤感粘腻。The preferred viscosity range of the foaming sheet mask liquid of the present invention is 120mPa·s~250mPa·s, so neither the mask liquid will flow because of the low viscosity, nor will the skin feel sticky because of the high viscosity.
作为本发明所述发泡贴片面膜组合物的优选实施方式,所述优选增稠稳泡剂的重量百分比为0.2%~0.8%。黄原胶和羟丙基甲基纤维素的优选添加质量比要考虑增稠效果、稳泡效果和肤感之间的平衡,测试配方如下表13。As a preferred embodiment of the foaming sheet mask composition of the present invention, the weight percentage of the preferred thickening and foam stabilizing agent is 0.2% to 0.8%. The optimal weight ratio of xanthan gum and hydroxypropyl methylcellulose should consider the balance between thickening effect, foam stabilizing effect and skin feel. The test formula is shown in Table 13 below.
表13黄原胶和羟丙基甲基纤维素的优选添加质量比实验配方The preferred addition mass ratio experimental formula of table 13 xanthan gum and hydroxypropyl methylcellulose
黄原胶和羟丙基甲基纤维素的添加总量之和为0.65%。上述配方的制备工艺参考实施例1中表5的制备工艺。The sum of the added total amount of xanthan gum and hydroxypropyl methylcellulose is 0.65%. For the preparation process of the above formula, refer to the preparation process in Table 5 in Example 1.
黄原胶和羟丙基甲基纤维素的不同质量比的增稠效果、稳泡效果和肤感的实验结果如下表14。The experimental results of the thickening effect, foam stabilizing effect and skin feeling of different mass ratios of xanthan gum and hydroxypropyl methylcellulose are shown in Table 14 below.
表14黄原胶和羟丙基甲基纤维素的不同质量比的实验结果The experimental results of the different mass ratios of table 14 xanthan gum and hydroxypropyl methylcellulose
从表14可以看出,本发明所述增稠稳泡剂中,黄原胶与羟丙基甲基纤维素的质量比为2:1~1:1时,增稠效果、稳泡效果和肤感之间获得平衡。As can be seen from Table 14, in the thickening and foam stabilizing agent of the present invention, when the mass ratio of xanthan gum and hydroxypropyl methylcellulose is 2:1~1:1, the thickening effect, foam stabilizing effect and Balance between skin feel.
实施例4表面活性剂和挥发剂质量比的筛选The screening of embodiment 4 surfactant and volatile agent mass ratio
表面活性剂和挥发剂质量比的筛选配方如下表15。The screening formula of surfactant and volatile agent mass ratio is shown in Table 15 below.
表15表面活性剂和挥发剂质量比的筛选配方The screening formula of table 15 surfactant and volatile agent mass ratio
上述配方的制备工艺参考实施例1中表5的制备工艺。For the preparation process of the above formula, refer to the preparation process in Table 5 in Example 1.
表面活性剂和挥发剂的质量比的筛选实验结果如图14所示。The screening experiment results of the mass ratio of surfactant and volatile agent are shown in FIG. 14 .
图15中,表面活性剂与挥发剂的5个不同质量比的筛选实验从上至下、从左至右,表面活性剂:挥发剂的质量比依次为3:1、2:1、1:1、1:2和1:3。从上图可以看出,表面活性剂的比例增加,发泡效果没有明显增加,且表面活性剂的增加,会增加潜在刺激性;而挥发剂的增加,发泡效果明显增加,但挥发剂增加则成本显著增加。因此,在综合成本,以及保证清洁效果和温和性的前提下,表面活性剂与挥发剂的优选质量比为表面活性剂:挥发剂=1:1~1:2。In Figure 15, the screening experiments of five different mass ratios of surfactants and volatile agents are from top to bottom and from left to right, and the mass ratios of surfactants: volatile agents are 3:1, 2:1, and 1: 1, 1:2 and 1:3. It can be seen from the above figure that the foaming effect does not increase significantly when the proportion of surfactant increases, and the increase of surfactant will increase the potential irritation; while the increase of volatile agent increases the foaming effect significantly, but the increase of volatile agent Then the cost increases significantly. Therefore, under the premise of comprehensive cost and ensuring cleaning effect and mildness, the preferred mass ratio of surfactant to volatile agent is surfactant: volatile agent=1:1~1:2.
实施例5面膜布柔软剂的筛选The screening of embodiment 5 mask cloth softening agent
本发明中使用的面膜布柔软剂选自天然多糖及其衍生物的至少一种,优选的面膜布柔软剂为羟乙基纤维素,且所述羟乙基纤维素的1%粘度范围3000mPa·s~6000mPa·s,摩尔取代比为2.5。The facial mask cloth softening agent used in the present invention is selected from at least one of natural polysaccharides and derivatives thereof, and the preferred facial mask cloth softening agent is hydroxyethyl cellulose, and the 1% viscosity range of hydroxyethyl cellulose is 3000mPa. s~6000mPa·s, the molar substitution ratio is 2.5.
面膜布柔软剂羟乙基纤维素可以改善面膜布的柔软性和贴服性,改善中等和加厚型面膜布以及交叉铺网织法且编织较均匀的薄型面膜布的延展性,更好地适应消费者的不同脸型。The mask cloth softener hydroxyethyl cellulose can improve the softness and fit of the mask cloth, improve the extensibility of the medium and thick mask cloth and the thin mask cloth with cross-laid net weave and uniform weaving, and better Adapt to different face shapes of consumers.
本发明的面膜液中,所述面膜布柔软剂的重量百分比为0.01%~0.2%。优选地,所述面膜布柔软剂的重量百分比为0.01%~0.1%。更为优选的,所述面膜布为竖纹织法面膜布时,所述面膜布柔软剂的重量百分比0.01%~0.05%。所述面膜布为横纹织法面膜布时,所述面膜布柔软剂的重量百分比0.01%~0.1%。In the facial mask liquid of the present invention, the weight percentage of the facial mask cloth softener is 0.01% to 0.2%. Preferably, the weight percentage of the facial mask cloth softener is 0.01%-0.1%. More preferably, when the facial mask cloth is a vertical weave facial mask cloth, the weight percentage of the facial mask cloth softener is 0.01%-0.05%. When the mask cloth is a horizontal weave mask cloth, the weight percentage of the mask cloth softener is 0.01%-0.1%.
面膜布柔软剂对比实验:使用厚型面膜布,加或不加面膜布柔软剂,由100名使用者评价面膜布的柔软贴服性和延展性,统计正面评价人数。实验组的配方如下表16。Comparative experiment of mask cloth softener: using a thick mask cloth with or without mask cloth softener, 100 users evaluated the softness, conformability and extensibility of the mask cloth, and counted the number of positive evaluations. The formulations of the experimental groups are shown in Table 16 below.
表16添加有面膜布柔软剂的实验组配方Table 16 is added with the experimental group formula of mask cloth softening agent
上述配方的制备工艺参考实施例1中表5的制备工艺。For the preparation process of the above formula, refer to the preparation process in Table 5 in Example 1.
对照组与实验组的区别仅在于:对照组不添加面膜布柔软剂。The difference between the control group and the experimental group is only: the control group does not add facial mask cloth softener.
使用者对上述实验组和对照组的面膜的使用评价结果如表17所示。Table 17 shows the evaluation results of users on the facial masks of the above-mentioned experimental group and control group.
表17评价结果Table 17 Evaluation Results
从表17的结果可看出,使用面膜布柔软剂可明显提升面膜的柔软贴服性和柔软性,进而提高面膜的使用舒适感。It can be seen from the results in Table 17 that the use of mask fabric softener can significantly improve the softness and flexibility of the mask, thereby improving the comfort of the mask.
实施例6面膜布的筛选The screening of embodiment 6 mask cloth
本发明所述面膜布可以选用天然纤维、化学纤维、混纺纤维中的至少一种,且所述面膜布为非网眼的致密单向铺网织法或交叉铺网织法。The facial mask cloth of the present invention can be selected from at least one of natural fibers, chemical fibers, and blended fibers, and the facial mask cloth is a non-mesh dense unidirectional weaving method or a cross-laid weaving method.
不同材质和织法的面膜布筛选实验如图15~16,所用面膜液配方如下表18。Screening experiments of mask cloths of different materials and weaving methods are shown in Figures 15-16, and the formula of the mask liquid used is shown in Table 18.
表18面膜布筛选实验配方Table 18 Mask Cloth Screening Experimental Formula
上述配方的制备工艺参考实施例1中表5的制备工艺。For the preparation process of the above formula, refer to the preparation process in Table 5 in Example 1.
从图15~16可看出,克重为45~65克、不同材质的面膜布都具有较好的发泡效果。其中,以克重为40克的棉质面膜布的泡沫质地最为细腻,克重为50克以上的厚型面膜布具有更好的面膜布形状保持能力,更易于铺展敷用。As can be seen from Figures 15-16, mask cloths with a gram weight of 45-65 grams and different materials all have good foaming effects. Among them, the foam texture of the cotton mask cloth with a gram weight of 40 grams is the most delicate, and the thick mask cloth with a gram weight of more than 50 grams has a better ability to maintain the shape of the mask cloth and is easier to spread and apply.
实施例7Example 7
本发明实施例7提供一种发泡贴片面膜,其包括面膜布和面膜液,所述面膜布为40克重的横纹天然棉,所述面膜液如下表19所示。Embodiment 7 of the present invention provides a foaming sheet mask, which includes a mask cloth and a mask liquid. The mask cloth is 40 grams of horizontal grain natural cotton, and the mask liquid is shown in Table 19 below.
表19实施7面膜液配方Table 19 implements 7 facial mask liquid formulas
所述面膜液的制备工艺参考实施例1中表5的制备工艺。For the preparation process of the mask liquid, refer to the preparation process in Table 5 in Example 1.
实施例8Example 8
本发明实施例8提供一种发泡贴片面膜,其包括面膜布和面膜液,所述面膜布为40克重的横纹天然棉,所述面膜液如下表20所示。Embodiment 8 of the present invention provides a foaming sheet mask, which includes a mask cloth and a mask liquid, the mask cloth is a 40-gram horizontal-grained natural cotton, and the mask liquid is shown in Table 20 below.
表20实施8面膜液配方Table 20 implements 8 facial mask liquid formulas
所述面膜液的制备工艺参考实施例1中表5的制备工艺。For the preparation process of the mask liquid, refer to the preparation process in Table 5 in Example 1.
实施例9Example 9
本发明实施例9提供一种发泡贴片面膜,其包括面膜布和面膜液,所述面膜布为40克重的横纹天然棉,所述面膜液的配方如下表21所示。Embodiment 9 of the present invention provides a foaming sheet mask, which includes a mask cloth and a mask liquid. The mask cloth is 40 grams of horizontal grain natural cotton, and the formula of the mask liquid is shown in Table 21 below.
表21实施9面膜液配方Table 21 implements 9 facial mask liquid formulas
所述面膜液的制备工艺参考实施例1中表5的制备工艺。For the preparation process of the mask liquid, refer to the preparation process in Table 5 in Example 1.
实施例10Example 10
本发明实施例10提供一种发泡贴片面膜,其包括面膜布和面膜液,所述面膜布为40克重的横纹天然棉,所述面膜液的配方如下表22所示。Embodiment 10 of the present invention provides a foaming sheet mask, which includes a mask cloth and a mask liquid. The mask cloth is 40 grams of horizontal grain natural cotton, and the formula of the mask liquid is shown in Table 22 below.
表22实施10面膜液配方Table 22 implements 10 facial mask liquid formulas
所述面膜液的制备工艺参考实施例1中表5的制备工艺。For the preparation process of the mask liquid, refer to the preparation process in Table 5 in Example 1.
实施例11Example 11
本发明实施例11提供一种发泡贴片面膜,其包括面膜布和面膜液,所述面膜布为40克重的横纹天然棉,所述面膜液的配方如下表23所示。Embodiment 11 of the present invention provides a foaming sheet mask, which includes a mask cloth and a mask liquid. The mask cloth is 40 grams of horizontal grain natural cotton, and the formula of the mask liquid is shown in Table 23 below.
表23实施11面膜液配方Table 23 implements 11 facial mask liquid formulas
所述面膜液的制备工艺参考实施例1中表5的制备工艺。For the preparation process of the mask liquid, refer to the preparation process in Table 5 in Example 1.
实施例12Example 12
对实施例7~11的面膜液进行CAMVA试验,试验结果如表24所示。The CAMVA test was carried out on the mask liquids of Examples 7-11, and the test results are shown in Table 24.
表24面膜液CAMVA试验的NC值Table 24 NC value of mask liquid CAMVA test
从表24的结果可看出,实施例7~11的面膜液的CAMVA试验NC值均≤3,说明本发明实施例7~11的面膜液性质温和。As can be seen from the results in Table 24, the CAMVA test NC values of the facial masks of Examples 7-11 are all ≤ 3, indicating that the facial masks of Examples 7-11 of the present invention are mild in nature.
实施例13Example 13
随机招募无皮肤过敏史的志愿者120名,年龄在18~45岁之间。120名志愿者随机分为6组,每组20人,分别敷用实施例7~11的面膜以及市售的保湿贴片面膜,敷用15分钟后去除面膜布,用清水洗去或用面巾纸擦去残留的面膜液,评价面膜的使用效果,对各测试项目进行评分,评分标准如表25所示。计算每组实验组的各测试项目的平均分,结果如表26所示。A total of 120 volunteers with no history of skin allergy were randomly recruited, aged between 18 and 45 years old. 120 volunteers were randomly divided into 6 groups, 20 people in each group, respectively applied the facial masks of Examples 7-11 and commercially available moisturizing sheet masks, removed the mask cloth after 15 minutes of application, washed it off with clear water or wiped it with facial tissue Wipe off the remaining mask liquid, evaluate the use effect of the mask, and score each test item. The scoring criteria are shown in Table 25. Calculate the average score of each test item in each experimental group, and the results are shown in Table 26.
表25评分标准Table 25 Scoring Criteria
表26面膜的使用效果统计Table 26 Statistics on the use effect of facial masks
从表26可以看出,本发明的面膜具有较佳的温和性和清洁效果,并能滋润肌肤,提亮肤色。实施例7~11的面膜中,综合效果以实施例7和实施例8的较好,考虑成本,因此本发明以实施例7的配方最为优选配方。As can be seen from Table 26, the facial mask of the present invention has better mildness and cleaning effect, and can moisturize the skin and brighten the complexion. Among the facial masks of Examples 7 to 11, the comprehensive effect is better with that of Example 7 and Example 8, considering the cost, so the formula of Example 7 is the most preferred formula in the present invention.
最后所应当说明的是,以上实施例仅用以说明本发明的技术方案而非对本发明保护范围的限制,尽管参照较佳实施例对本发明作了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的实质和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than limit the protection scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that The technical solution of the present invention can be modified or equivalently replaced without departing from the spirit and scope of the technical solution of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910374527.3A CN110141528A (en) | 2019-05-05 | 2019-05-05 | A kind of foam sheet mask |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910374527.3A CN110141528A (en) | 2019-05-05 | 2019-05-05 | A kind of foam sheet mask |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110141528A true CN110141528A (en) | 2019-08-20 |
Family
ID=67594717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910374527.3A Pending CN110141528A (en) | 2019-05-05 | 2019-05-05 | A kind of foam sheet mask |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110141528A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110585090A (en) * | 2019-10-21 | 2019-12-20 | 广州艾蓓生物科技有限公司 | Self-foaming red mud mask and preparation method thereof |
CN115052580A (en) * | 2020-02-13 | 2022-09-13 | 拜尔斯道夫股份有限公司 | Polyacrylate-free cosmetic preparations |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8832298A (en) * | 1997-10-16 | 1999-05-06 | Smiths Group Plc | Laryngeal mask assemblies |
CN101744743A (en) * | 2008-11-28 | 2010-06-23 | 高宝化妆品(中国)有限公司 | Self-foaming skin-cleaning mask and preparation method thereof |
CN103181861A (en) * | 2011-12-30 | 2013-07-03 | 广东雅威生物科技有限公司 | Bubble facial mask and preparation process thereof |
CN104921960A (en) * | 2014-03-18 | 2015-09-23 | 株式会社韩国化妆品制造 | Mask sheet cosmetic composition with self foaming function and manufacturing method thereof |
CN109464292A (en) * | 2018-10-11 | 2019-03-15 | 珀莱雅化妆品股份有限公司 | One kind is mildly from foam mask |
-
2019
- 2019-05-05 CN CN201910374527.3A patent/CN110141528A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8832298A (en) * | 1997-10-16 | 1999-05-06 | Smiths Group Plc | Laryngeal mask assemblies |
CN101744743A (en) * | 2008-11-28 | 2010-06-23 | 高宝化妆品(中国)有限公司 | Self-foaming skin-cleaning mask and preparation method thereof |
CN103181861A (en) * | 2011-12-30 | 2013-07-03 | 广东雅威生物科技有限公司 | Bubble facial mask and preparation process thereof |
CN104921960A (en) * | 2014-03-18 | 2015-09-23 | 株式会社韩国化妆品制造 | Mask sheet cosmetic composition with self foaming function and manufacturing method thereof |
CN109464292A (en) * | 2018-10-11 | 2019-03-15 | 珀莱雅化妆品股份有限公司 | One kind is mildly from foam mask |
Non-Patent Citations (1)
Title |
---|
珀莱雅化妆品股份有限公司: "《http://ftba.nmpa.gov.cn:8181/ftban/itownet/hzp_ba/fw/pz.jsp?processid=20180911092925xxg20&nid=20180911092925xxg20》", 18 September 2018 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110585090A (en) * | 2019-10-21 | 2019-12-20 | 广州艾蓓生物科技有限公司 | Self-foaming red mud mask and preparation method thereof |
CN110585090B (en) * | 2019-10-21 | 2022-06-17 | 广州艾蓓生物科技有限公司 | Self-foaming red mud mask and preparation method thereof |
CN115052580A (en) * | 2020-02-13 | 2022-09-13 | 拜尔斯道夫股份有限公司 | Polyacrylate-free cosmetic preparations |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107260579B (en) | A kind of mild face cleaning bubble and preparation method thereof | |
JP5947121B2 (en) | Liquid cleaner in non-gas former container | |
CN104224575B (en) | It is a kind of transparent without silicone oil hair-washing composition and preparation method thereof | |
CN109381363A (en) | A kind of amino acid shampoo and preparation method thereof | |
CN110151578A (en) | A kind of clean face cream of amino acid skin-active and preparation method thereof of mild cleaning moisturizing | |
CN108096173A (en) | Mild amino acid shampoo of a kind of green and preparation method thereof | |
CN102716044A (en) | Low-stimulation hair-cleaning compound | |
JP2012158547A (en) | Detergent composition | |
CN109528505B (en) | Mild moisturizing and soothing skin-cleaning bubble composition | |
CN115300405B (en) | Hair composition with color protection effect and preparation method and application thereof | |
CN107595735A (en) | A kind of amino acid cleansing breast containing folium artemisiae argyi and preparation method thereof | |
CN109864933A (en) | A kind of hair of children cleaning compositions of not silicate-containing oil and preparation method thereof | |
CN106999391A (en) | Cleaning products | |
CN110327257A (en) | A kind of transparent amino acid shampoo with treatment | |
CN110141528A (en) | A kind of foam sheet mask | |
CN108904311A (en) | A kind of no silicone oil shampoo | |
JP6694343B2 (en) | Skin cleanser composition | |
CN114010520A (en) | Personal care composition, preparation method and application | |
WO2022127421A1 (en) | Cleaning composition | |
CN113081889A (en) | Three-stage washing and protecting integrated composition | |
CN115414272B (en) | Female bubble shampoo without irritation in eyes and preparation method thereof | |
KR100815069B1 (en) | Detergent composition | |
CN109044881B (en) | Pearlescent shampoo composition and preparation method thereof | |
CN110693771A (en) | Washing care product containing micro-nano emulsion | |
JP5758639B2 (en) | Cleaning composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190820 |
|
RJ01 | Rejection of invention patent application after publication |